PLIANT THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-55.9M | $-47.0M | $-41.1M | $-41.5M | $-41.2M | $-37.5M | $-35.1M | $-30.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $600.0K | $513.0K | $489.0K | $500.0K | $400.0K | $452.0K | $468.0K | $500.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $10.6M | $9.7M | $9.2M | $10.4M | $13.0M | $11.9M | $10.9M | $4.8M |
| Net Cash from Operating Activities | $-45.3M | $-30.3M | $-25.1M | $-36.2M | $-24.8M | $-30.3M | $-31.2M | $-18.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.3M | $1.5M | $61.0K | $94.0K | $603.0K | $163.0K | $166.0K | $696.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $10.7M | $59.5M | $31.9M | $38.3M | $-23.0M | $-174.2M | $20.0M | $-178.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $684.0K | $21.8M | $219.0K | $699.0K | $161.0K | $273.3M | $284.0K | $216.3M |
| Net Change in Cash | $-33.9M | $51.1M | $7.0M | $2.7M | $-47.6M | $68.8M | $-10.9M | $19.5M |
| Free Cash Flow | $-46.5M | $-31.8M | $-25.2M | $-36.3M | $-25.4M | $-30.4M | $-31.4M | $-19.2M |